UFP Technologies Announces Record Full-Year 2025 Results; Delivers Strong Q4 Performance
Newburyport, MA – February 24, 2026 – UFP Technologies, Inc. (NASDAQ: UFPT), a designer and custom manufacturer of engineered solutions for the medical and advanced applications markets, has reported record financial results for the fourth quarter and full year ended December 31, 2025. The company’s performance continued its trend of robust growth, marked by a significant increase in both sales and profitability.
Key Financial Highlights
- Full-Year 2025 Net Sales: \$602.8 million, up 19.5% from \$504.4 million in 2024.
- Fourth Quarter 2025 Sales: \$148.9 million, a 3.4% increase over Q4 2024’s \$144.1 million.
- GAAP Earnings Per Diluted Share (EPS) for 2025: \$8.75.
- Adjusted EPS for 2025: \$9.76.
- Net Income (GAAP) for 2025: \$68.3 million.
- Adjusted Net Income for 2025: \$67.6 million.
- Gross Profit (GAAP) for 2025: \$146.7 million.
- Adjusted Gross Profit Margin: 29.3% (2024: 28.3%).
- SG&A (GAAP): \$77.4 million; Adjusted SG&A: \$62.2 million.
- Adjusted EBITDA for 2025: \$92.3 million.
Detailed Operational and Financial Analysis
UFP Technologies continued its strong growth trajectory in 2025, achieving a 19.5% year-over-year increase in revenues. The company’s fourth quarter revenue of \$148.9 million also marked a notable improvement over the prior year’s comparable period. The growth was driven by continued expansion in its medical and advanced technology markets, as well as successful integration of recent acquisitions.
Profitability also saw significant improvement, with GAAP net income for the year reaching \$68.3 million and adjusted net income at \$67.6 million. GAAP EPS for the year was \$8.75, with adjusted EPS at \$9.76, highlighting the company’s ability to generate strong earnings and operating leverage.
- Gross Profit: The company maintained healthy gross profit margins, with adjusted gross profit margin improving to 29.3% from 28.3% the prior year. This reflects operational efficiencies and effective cost management.
- SG&A Expenses: On a GAAP basis, SG&A expenses were \$77.4 million, with adjustments bringing this down to \$62.2 million, as the company continues to focus on disciplined spending and integration synergies.
- Adjusted EBITDA: UFP Technologies reported adjusted EBITDA of \$92.3 million, indicating continued strength in cash generation and operational performance.
Balance Sheet and Liquidity
- Total Assets at December 31, 2025: \$655.1 million, up from \$567.6 million at the end of 2024.
- Goodwill: \$197.4 million (2024: \$189.7 million), reflecting the impact of acquisitions.
- Intangible Assets (Net): \$140.8 million (2024: \$135.6 million).
- Total Equity: \$423.9 million (2024: \$342.8 million).
Shareholder-Relevant and Price-Sensitive Information
- Record Sales and Earnings: The company’s record performance, especially the double-digit sales growth and EPS expansion, signals strong underlying business momentum and may positively impact share valuation.
- Margin Expansion: The improvement in gross profit margins and disciplined SG&A management are likely to be viewed favorably by investors.
- Acquisition Integration: The company continues to successfully integrate acquisitions, contributing to top-line growth and enhancing its product and customer base.
- Forward-Looking Statements: Management noted that, excluding historical information, certain statements in the press release are forward-looking and subject to risks, including those related to market conditions, acquisition performance, and competitive dynamics. Investors should carefully consider these risks.
Non-GAAP Financial Measures
The company provides non-GAAP measures such as adjusted EPS, adjusted net income, and adjusted EBITDA to give investors additional insight into operational performance. These measures exclude certain items such as purchase accounting adjustments, amortization of intangible assets, and share-based compensation.
Outlook
UFP Technologies’ management expressed optimism about continued growth, citing its strong market position, integration of recent acquisitions, and ongoing opportunities in medical and advanced applications markets. The company plans to maintain its focus on operational excellence and strategic investments to drive further value for shareholders.
Important Dates and Information
- Conference Call/Webcast: A live webcast of the conference call and materials are available at ufpt.com/investors. A replay is accessible following the event.
- Ticker: NASDAQ: UFPT
- Security: Common Stock
Disclaimer
This article contains forward-looking statements based on current expectations, estimates, and projections about UFP Technologies and its markets. These statements involve risks and uncertainties that could cause actual results to differ materially. Investors are advised to review the company’s SEC filings for a full discussion of the risks and uncertainties facing the business. The information provided herein is not investment advice. Please consult your financial advisor before making any investment decisions.
View UFP TECHNOLOGIES INC Historical chart here
